HORMONES AND HAIR REGROWTH FOR WOMEN| DR DRAY

HORMONES AND HAIR REGROWTH FOR WOMEN| DR DRAY

HORMONES AND HAIR REGROWTH IN WOMEN: FINASTERIDE, DUTASTERIDE, SPIRONOLACTONE, CYPROTERONE, FLUTAMIDE & BIRTH CONTROL PILLS.

THIS VIDEO IS NOT SPONSORED.

💜REFERENCES
Atanaskova Mesinkovska N, BergfeldWF. Hair:What is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment. Dermatol Clin 2013;31:119–27.
Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol 2014;80:521–5.
Bowman CJ, Barlow NJ, Turner KJ,Wallace DG, Foster PM. Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat. Toxicol Sci 2003;74:393–406.
Burger HG. Androgen production in women. Fertil Steril 2002;77:S3–5.
Camacho FM, Garcia-Hernandez M. Psychological features of androgenetic alopecia. J Eur Acad Dermatol Venereol 2002;16:476–80.
Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril 2003;79:91–5.
Cousen P, Messenger A. Female pattern hair loss in complete androgen insensitivity syndrome. Br J Dermatol 2010;162:1135–7.
Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 2002;4:1–11.
Famenini S, Slaught C, Duan L, Goh C. Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. J Am Acad Dermatol 2015;73:705–6.
Gupta AK, Charrette A. The efficacy and safety of 5alpha-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat 2014;25:156–61.
Harfmann KL, Bechtel MA. Hair loss in women. Clin Obstet Gynecol 2015;58:185–99.
Hoffmann R, Niiyama S, Huth A, Kissling S, Happle R. 17alpha estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol 2002;11:376–80.
Iorizzo M, Vincenzi C, Voudouris S, Piraccini BM, Tosti A. Finasteride treatment of female pattern hair loss. Arch Dermatol 2006;142:298–302.
KimWJ, SongM, Ko HC, KimBS, KimMB. Efficacy of finasteride 1.25mg on female pattern hair loss; pilot study. Ann Dermatol 2012;24:370–2.
Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Womens Health 2013;5:541–56.
Medicines and Healthcare products Regulatory Agency. High-dose cyproterone acetate: potential risk of (multiple) meningiomas. Drug Safety Update 2009; 3:3–4.
Olsen EA, Hordinsky M,Whiting D, Stough D, Hobbs S, Ellis ML, et al. The importance
of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 2006;55:1014–23.
Olszewska M, Rudnicka L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol 2005;4:637–40.
Orme S, Cullen DR, Messenger AG. Diffuse female hair loss: are androgens necessary? Br J Dermatol 1999;141:521–3.
Paradisi R, Porcu E, Fabbri R, Seracchioli R, Battaglia C, Venturoli S. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss. Ann Pharmacother 2011;45:469–75.
Park J, Kim JI, Yun SK, Kim HU, Ihm CW. Pattern alopecia during hormonal anticancer therapy in patients with breast cancer. Ann Dermatol 2014;26:743–6.
Peereboom-Wynia JD, van derWilligen AH, van Joost T, Stolz E. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females. Acta Derm Venereol 1989;69:395–8.
Scheinfeld N. A review of hormonal therapy for female pattern (androgenic) alopecia. Dermatol Online J 2008;14:1.
Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab 2013;11:41–7.
Schmidt TH, Shinkai K. Evidence-based approach to cutaneous hyperandrogenism in
women. J Am Acad Dermatol 2015;73:672–90.
Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 2005;152:466–73.

💜Subscribe!

💜Social media
Instagram @drdrayzday
Facebook @DrDrayzDay
Twitter: @drdrayzday

📪Mail:
PO Box 542234
Houston, TX 77254

Disclaimer: This video is not intended to provide diagnosis, treatment or medical advice. Content provided on this Youtube channel is for informational purposes only. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options. Information on this Youtube channel should not be considered as a substitute for advice from a healthcare professional. The statements made about specific products throughout this video are not to diagnose, treat, cure or prevent disease.